Almost 50% of people vaccinated with EpiVacCorona lost their antibodies in nine months

“As of three and six months, we record the presence of antibodies in all vaccinated volunteers. As of nine months, more than half of the volunteers also have a detectable level of antibodies to the virus", - Rinat Maksyutov, general director of the Vector Center, said in an interview with Russia 24.

The EpiVacCorona vaccine is a peptide vaccine. The drug was developed at the Vector Scientific Center of Rospotrebnadzor and registered in October 2020. However, in society, this vaccine causes a mixed reaction. Activists sound the alarm and ask to check EpiVacCorona: they are sure that this vaccine is useless. However, the Ministry of Health said that since the drug is registered, then everything is in order with it.